TransGenRx

TransGenRx develops technology to produce protein based drugs by using avian cell line and vector systems.

TransGenRx, a biopharmaceutical manufacturing company, has developed technology that significantly reduces the cost of producing protein-based drugs by using a high expressing avian cell line combined with their patented vector system. Patented and patent pending processes allow TGRx to develop custom proteins to meet a wide range of specifications. Use the links on the left to learn more about our team as well as the products and services we offer through our patent and patent pending technologies.